China Universal Asset Management Company’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
China Universal Asset Management Company's RIGL Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Rigel Pharmaceuticals (RIGL) stake by 8.6% in Q2 2026, selling an estimated $8.51K and leaving 2,945 shares worth $115K. The position accounts for 0.01% of the portfolio, ranked #402.
China Universal Asset Management Company first reported a position in RIGL in Q3 2022 and has held it in 8 quarters since. The position peaked at $127K in Q4 2025. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.
- China Universal Asset Management Company held 2,945 shares of Rigel Pharmaceuticals worth $115K as of Q2 2026.
- China Universal Asset Management Company sold 276 Rigel Pharmaceuticals shares in Q2 2026, an estimated $8.51K.
- Rigel Pharmaceuticals made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #402 holding.
- China Universal Asset Management Company first reported a position in Rigel Pharmaceuticals in Q3 2022 and has held it in 8 quarters since.
- China Universal Asset Management Company's Rigel Pharmaceuticals position peaked at $127K in Q4 2025.
- 155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.